TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE (USD BILLION)
6.1. Interventional Neurology Devices
6.2. Neurovascular Stents
6.3. Embolic Agents
6.4. Catheters
6.5. Flow Diverters
7. NEUROVASCULAR DEVICES MARKET, BY APPLICATION (USD BILLION)
7.1. Aneurysm Treatment
7.2. Arteriovenous Malformation Treatment
7.3. Intracranial Atherosclerotic Disease
7.4. Ischemic Stroke
7.5. Hemorrhagic Stroke
8. NEUROVASCULAR DEVICES MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Ambulatory Surgical Centers
8.3. Specialty Clinics
9. NEUROVASCULAR DEVICES MARKET, BY REGIONAL (USD BILLION)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Russia
9.2.5. Italy
9.2.6. Spain
9.2.7. Rest of Europe
9.3. APAC
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Malaysia
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Rest of APAC
9.4. South America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of South America
9.5. MEA
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of MEA
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market share Analysis
10.4. Major Growth Strategy in the Neurovascular Devices Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Neurovascular Devices Market
10.7. Key developments and growth strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales and Operating Income
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. Asahi Intecc
11.1.1. Financial Overview
11.1.2. Products Offered
11.1.3. Key Developments
11.1.4. SWOT Analysis
11.1.5. Key Strategies
11.2. Neuronetics
11.2.1. Financial Overview
11.2.2. Products Offered
11.2.3. Key Developments
11.2.4. SWOT Analysis
11.2.5. Key Strategies
11.3. Medtronic
11.3.1. Financial Overview
11.3.2. Products Offered
11.3.3. Key Developments
11.3.4. SWOT Analysis
11.3.5. Key Strategies
11.4. Sahajanand Medical Technologies
11.4.1. Financial Overview
11.4.2. Products Offered
11.4.3. Key Developments
11.4.4. SWOT Analysis
11.4.5. Key Strategies
11.5. MicroVention
11.5.1. Financial Overview
11.5.2. Products Offered
11.5.3. Key Developments
11.5.4. SWOT Analysis
11.5.5. Key Strategies
11.6. Acandis
11.6.1. Financial Overview
11.6.2. Products Offered
11.6.3. Key Developments
11.6.4. SWOT Analysis
11.6.5. Key Strategies
11.7. Abbott Laboratories
11.7.1. Financial Overview
11.7.2. Products Offered
11.7.3. Key Developments
11.7.4. SWOT Analysis
11.7.5. Key Strategies
11.8. Cerenovus
11.8.1. Financial Overview
11.8.2. Products Offered
11.8.3. Key Developments
11.8.4. SWOT Analysis
11.8.5. Key Strategies
11.9. Boston Scientific
11.9.1. Financial Overview
11.9.2. Products Offered
11.9.3. Key Developments
11.9.4. SWOT Analysis
11.9.5. Key Strategies
11.10. iVascular
11.10.1. Financial Overview
11.10.2. Products Offered
11.10.3. Key Developments
11.10.4. SWOT Analysis
11.10.5. Key Strategies
11.11. Johnson and Johnson
11.11.1. Financial Overview
11.11.2. Products Offered
11.11.3. Key Developments
11.11.4. SWOT Analysis
11.11.5. Key Strategies
11.12. Neuravi
11.12.1. Financial Overview
11.12.2. Products Offered
11.12.3. Key Developments
11.12.4. SWOT Analysis
11.12.5. Key Strategies
11.13. Stryker
11.13.1. Financial Overview
11.13.2. Products Offered
11.13.3. Key Developments
11.13.4. SWOT Analysis
11.13.5. Key Strategies
11.14. Penumbra
11.14.1. Financial Overview
11.14.2. Products Offered
11.14.3. Key Developments
11.14.4. SWOT Analysis
11.14.5. Key Strategies
11.15. Terumo
11.15.1. Financial Overview
11.15.2. Products Offered
11.15.3. Key Developments
11.15.4. SWOT Analysis
11.15.5. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 6. US NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 7. US NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 8. US NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 9. US NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 10. CANADA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 11. CANADA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 16. EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 18. GERMANY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 19. GERMANY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 20. GERMANY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 21. GERMANY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. UK NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. UK NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 24. UK NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 25. UK NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. FRANCE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 27. FRANCE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 28. FRANCE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 29. FRANCE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 30. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 31. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 32. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 33. RUSSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 34. ITALY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 35. ITALY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 36. ITALY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 37. ITALY NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. SPAIN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 39. SPAIN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 40. SPAIN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 41. SPAIN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. REST OF EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. REST OF EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 44. REST OF EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 45. REST OF EUROPE NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 46. APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 47. APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 48. APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 49. APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. CHINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. CHINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 52. CHINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 53. CHINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 54. INDIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. INDIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 56. INDIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 57. INDIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 58. JAPAN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 59. JAPAN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 60. JAPAN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 61. JAPAN NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 64. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 65. SOUTH KOREA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 66. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 67. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 68. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 69. MALAYSIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 70. THAILAND NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 71. THAILAND NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 72. THAILAND NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 73. THAILAND NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 76. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 77. INDONESIA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 78. REST OF APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 79. REST OF APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 80. REST OF APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 81. REST OF APAC NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 84. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 85. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 87. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 88. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 89. BRAZIL NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 90. MEXICO NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 91. MEXICO NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 92. MEXICO NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 93. MEXICO NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 94. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 95. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 96. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 97. ARGENTINA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 104. MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 105. MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 106. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 107. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 108. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 109. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 112. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 113. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 114. REST OF MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY DEVICE TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. REST OF MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF MEA NEUROVASCULAR DEVICES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 118. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 119. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS
FIGURE 3. US NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 4. US NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 5. US NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 6. US NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 7. CANADA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 8. CANADA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 9. CANADA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 10. CANADA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 11. EUROPE NEUROVASCULAR DEVICES MARKET ANALYSIS
FIGURE 12. GERMANY NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 13. GERMANY NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 14. GERMANY NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 15. GERMANY NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 16. UK NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 17. UK NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 18. UK NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 19. UK NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 20. FRANCE NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 21. FRANCE NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 22. FRANCE NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 23. FRANCE NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 24. RUSSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 25. RUSSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 26. RUSSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 27. RUSSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 28. ITALY NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 29. ITALY NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 30. ITALY NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 31. ITALY NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 32. SPAIN NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 33. SPAIN NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 34. SPAIN NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 35. SPAIN NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 36. REST OF EUROPE NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 37. REST OF EUROPE NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 38. REST OF EUROPE NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 39. REST OF EUROPE NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 40. APAC NEUROVASCULAR DEVICES MARKET ANALYSIS
FIGURE 41. CHINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 42. CHINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 43. CHINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 44. CHINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 45. INDIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 46. INDIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 47. INDIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 48. INDIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 49. JAPAN NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 50. JAPAN NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 51. JAPAN NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 52. JAPAN NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 53. SOUTH KOREA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 54. SOUTH KOREA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 55. SOUTH KOREA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 56. SOUTH KOREA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 57. MALAYSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 58. MALAYSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 59. MALAYSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 60. MALAYSIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 61. THAILAND NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 62. THAILAND NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 63. THAILAND NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 64. THAILAND NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDONESIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 66. INDONESIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 67. INDONESIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 68. INDONESIA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 69. REST OF APAC NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 70. REST OF APAC NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 71. REST OF APAC NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 72. REST OF APAC NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 73. SOUTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS
FIGURE 74. BRAZIL NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 75. BRAZIL NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 76. BRAZIL NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 77. BRAZIL NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 78. MEXICO NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 79. MEXICO NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 80. MEXICO NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 81. MEXICO NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 82. ARGENTINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 83. ARGENTINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 84. ARGENTINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 85. ARGENTINA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 86. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 87. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 88. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 89. REST OF SOUTH AMERICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 90. MEA NEUROVASCULAR DEVICES MARKET ANALYSIS
FIGURE 91. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 92. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 93. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 94. GCC COUNTRIES NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 95. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 96. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 97. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 98. SOUTH AFRICA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 99. REST OF MEA NEUROVASCULAR DEVICES MARKET ANALYSIS BY DEVICE TYPE
FIGURE 100. REST OF MEA NEUROVASCULAR DEVICES MARKET ANALYSIS BY APPLICATION
FIGURE 101. REST OF MEA NEUROVASCULAR DEVICES MARKET ANALYSIS BY END USE
FIGURE 102. REST OF MEA NEUROVASCULAR DEVICES MARKET ANALYSIS BY REGIONAL
FIGURE 103. KEY BUYING CRITERIA OF NEUROVASCULAR DEVICES MARKET
FIGURE 104. RESEARCH PROCESS OF MRFR
FIGURE 105. DRO ANALYSIS OF NEUROVASCULAR DEVICES MARKET
FIGURE 106. DRIVERS IMPACT ANALYSIS: NEUROVASCULAR DEVICES MARKET
FIGURE 107. RESTRAINTS IMPACT ANALYSIS: NEUROVASCULAR DEVICES MARKET
FIGURE 108. SUPPLY / VALUE CHAIN: NEUROVASCULAR DEVICES MARKET
FIGURE 109. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2024 (% SHARE)
FIGURE 110. NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2019 TO 2032 (USD Billions)
FIGURE 111. NEUROVASCULAR DEVICES MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 112. NEUROVASCULAR DEVICES MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 113. NEUROVASCULAR DEVICES MARKET, BY END USE, 2024 (% SHARE)
FIGURE 114. NEUROVASCULAR DEVICES MARKET, BY END USE, 2019 TO 2032 (USD Billions)
FIGURE 115. NEUROVASCULAR DEVICES MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 116. NEUROVASCULAR DEVICES MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 117. BENCHMARKING OF MAJOR COMPETITORS
